Wharton Business Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-9,938
| Closed | -$499K | – | 125 |
|
|
2016
Q2 | $499K | Sell |
9,938
-309
| -3% | -$15.5K | 0.06% | 95 |
|
|
2016
Q1 | $548K | Hold |
10,247
| – | – | 0.06% | 95 |
|
|
2015
Q4 | $673K | Hold |
10,247
| – | – | 0.07% | 92 |
|
|
2015
Q3 | $579K | Sell |
10,247
-2,625
| -20% | -$148K | 0.06% | 95 |
|
|
2015
Q2 | $761 | Sell |
12,872
-400
| -3% | -$24 | 0.05% | 96 |
|
|
2015
Q1 | $827K | Sell |
13,272
-917
| -6% | -$57.1K | 0.07% | 103 |
|
|
2014
Q4 | $816K | Hold |
14,189
| – | – | 0.07% | 99 |
|
|
2014
Q3 | $763K | Buy |
14,189
+1,095
| +8% | +$58.9K | 0.07% | 105 |
|
|
2014
Q2 | $686K | Sell |
13,094
-1,735
| -12% | -$90.9K | 0.08% | 108 |
|
|
2014
Q1 | $784K | Hold |
14,829
| – | – | 0.06% | 117 |
|
|
2013
Q4 | $594K | Hold |
14,829
| – | – | 0.05% | 121 |
|
|
2013
Q3 | $560K | Hold |
14,829
| – | – | 0.05% | 119 |
|
|
2013
Q2 | $581K | Buy |
+14,829
| New | +$581K | 0.05% | 118 |
|